Prediabetes Linked to Increased Risk of Stroke

Share this article:
Prediabetes Linked to Increased Risk of Stroke
Prediabetes Linked to Increased Risk of Stroke

(HealthDay News) – Prediabetes may be associated with a higher risk of future stroke if defined as impaired glucose tolerance or a combination of impaired fasting glucose and impaired glucose tolerance.

To assess the association between prediabetes and the risk of stroke, Meng Lee, MD, of the Chang Gung Memorial Hospital in Chiayi, Taiwan, and colleagues conducted a systematic review and meta-analysis of 15 prospective cohort studies involving 760,925 patients.

The researchers found that, in eight studies defining prediabetes as fasting glucose of 100–125mg/dL, after adjustment for established risk factors there was no significant association with stroke. In five studies defining prediabetes as fasting glucose of 110–125mg/dL, after adjustment there was a significantly increased risk of stroke (relative risk [RR], 1.21; P=0.03). In eight studies with information about impaired glucose tolerance with or without impaired fasting glucose, after adjustment there was an increased risk of stroke (RR, 1.26; P<0.001). After exclusion of studies that may have enrolled patients with diabetes, impaired glucose tolerance with or without impaired fasting glucose was independently associated with an increased risk of stroke, after adjustment (RR, 1.20; P=0.002).

"An immediate implication of our findings is that people with prediabetes should be aware that they are at increased risk of future stroke," the authors write. "Our study also underscored a need to evaluate both fasting glucose and two hour postprandial glucose challenge for identifying people with prediabetes who may be at risk of stroke."

Full Text
Editorial (subscription or payment may be required)

Share this article:
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters


What is this?

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs